Nexalin Technology, Inc. Common Stock (NXL) is a publicly traded Healthcare sector company. As of May 19, 2026, NXL trades at $0.33 with a market cap of $7.05M and a P/E ratio of -0.67. NXL moved -0.28% today. Year to date, NXL is -44.30%; over the trailing twelve months it is -74.45%. Its 52-week range spans $0.31 to $4.49. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces NXL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own NXL include Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nexalin Technology, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $0.33 |
| Market Cap | $7.05M |
| P/E Ratio | -0.67 |
| EPS | $-0.47 |
| Dividend Yield | 0.31% |
| 52-Week High | $4.49 |
| 52-Week Low | $0.31 |
| Volume | 668.98K |
| Avg Volume | 0 |
| Revenue (TTM) | $275.58K |
| Net Income | $-8.33M |
| Gross Margin | 81.99% |
1 analysts cover NXL: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.